Case Study: A Leading Biotech Company Streamlines P2P and OTC Processes

A prominent biotechnology company based in the United States, known for its expertise in manufacturing synthetic DNA, faced significant challenges in managing its financial processes. Rapid growth since inception has led to a substantial increase in the complexity and volume of financial transactions handled by the company’s Accounts Receivable (AR) and Accounts Payable (AP) teams.